Close

Trevena (TRVN) Reports FDA Advisory Committee to Review Oliceridine for Treatment of Moderate to Severe Acute Pain

October 11, 2018 7:08 AM EDT Send to a Friend
Trevena, Inc. (NASDAQ: TRVN) today announced that NASDAQ has halted trading of the Company’s common stock.The U.S. Food and Drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login